NCT02192372

Metabolic Syndrome and Contrast Induced Nephropathy

Impact of Metabolic Syndrome on Development of Contrast Induced Nephropathy After Elective Percutaneous Coronary Intervention

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 599 (actual)
• Sponsor: Ankara University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Prevention of contrast induced nephropathy after interventional cardiologic procedures deserves close interest because of its association with prolonged hospitalization, increased cost and increased in hospital and long term mortality rates. An observational prospective cohort study was designed to determine whether metabolic syndrome predicts the development of contrast induced nephropathy after elective percutaneous coronary intervention.

Conditions

• Contrast Induced Nephropathy
• Metabolic Syndrome

Timeline

• Start date: 2014-02-01
• Primary completion: 2014-07-01
• Completion: 2014-07-01
• First posted: 2014-07-16
• Last updated: 2014-07-16

Locations

1 site across 1 country: Turkey (Türkiye)